Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.
Veronica Hackethal, MD
A new open-label randomized controlled trial finds use of CGM in T1DM pregnancies may improve neonatal outcomes.
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
Timing appears to be nearly everything when it comes to the impact of respiratory infection on autoantibody seroconversion in infants at risk for tpye 1 diabetes.
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.
Results of a small systematic review identify a vulnerable ethnic group members of which may be patients in your practice.
True or false: Between 1999-2004 and 2005-2010, cancer replaced CV/CHD as leading cause of death in T2D.
The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.
Click through a short list of electronic medical records ranked highly for endocrinology practices.
How much of which foods truly promote cardiometabolic health? First-of-its-kind study quantifies impact of good food and bad.